Epitalon — Half-Life, Dosing & Protocol Guide

Also known as: Epithalon, Ala-Glu-Asp-Gly, Tetrapeptide-7

Preclinical· Half-life from Community estimate — no peer-reviewed human pharma

Plasma Half-Life

No published human PK data

Source: Community estimate — no peer-reviewed human pharmacokinetic study

Route

Subcutaneous / Intranasal

Frequency

Daily during cycle (10–20 days)

Standard Dose

5–10mg SC daily

Pharmacokinetics & Mechanism

Epitalon (Ala-Glu-Asp-Gly) is a synthetic tetrapeptide developed by the Khavinson laboratory from the pineal peptide preparation epithalamin. No peer-reviewed human pharmacokinetic study has been published. As a tetrapeptide, plasma clearance is expected to be rapid (minutes) based on peptide size, though functional effects (telomerase activation) are reported to persist beyond plasma exposure. Standard community cycling protocol: 5–10mg SC daily for 10–20 days, repeated 2–3× per year.

⚠ No Published Human PK Data
Half-life values for this compound are based on preclinical (animal) studies or community estimates only. These cannot be assumed to apply to humans.

Track Epitalon in Halflife

The Halflife app tracks your Epitalon protocol with real-time concentration curves, dose logging, injection site rotation, and vial inventory — all on-device with no account required.

See your Epitalon curve live

Real-time concentration model based on your actual dose and injection time. Free iOS app.

Download on App Store